Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Amicus Therapeutics Inc FOLD

Healthcare Biotechnology
Amicus Therapeutics, Inc. is a biotechnology company, which is focused on discovering, developing, and delivering novel medicines for rare diseases. Its two marketed therapies are Galafold, the first oral monotherapy for people living with Fabry disease who have amenable genetic variants, and Pombiliti + Opfolda, a novel treatment designed to improve uptake of active enzyme into key disease... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:FOLD)

Amicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates

GlobeNewswire November 6, 2024

Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024

GlobeNewswire November 1, 2024

Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024

GlobeNewswire October 28, 2024

Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with Teva

GlobeNewswire October 17, 2024

Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024

GlobeNewswire October 4, 2024

Kaskela Law LLC Announces Shareholder Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Investors to Contact the Firm

Business Wire September 17, 2024

UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024

GlobeNewswire September 3, 2024

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024

GlobeNewswire September 3, 2024

Amicus Therapeutics Announces Participation at the SSIEM 2024 Annual Symposium

GlobeNewswire September 3, 2024
View More News ››

Opinion & Analysis (NDAQ:FOLD)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:FOLD)

Buy Recommendation Issued On FOLD By Bank of America Securit

Just In: $FOLD Buy Recommendation Issued On FOLD By Bank of America Securities2024-10-17 13:15:05 ET Bank of America Securities analyst...
whytestocks - October 17, 2024

Amicus Therapeutics Announces Second Quarter 2024 Financial

News; $FOLD Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate UpdatesQ2 2024 Total Revenue of $126.7M, a...
whytestocks - August 8, 2024

7 THINGS TO KNOW ABOUT AMICUS THERAPEUTICS

$FOLD   Amicus Therapeutics, Inc. (NASDAQ: FOLD), a biotechnology company developing cutting-edge therapeutics for treatment...
AviseAnalytics - March 2, 2022

RE:$FOLD upgraded $CTRV $AVXL $TBPH & $ASTI

Hi, what do you mean by FOLD upgraded? its going down! any input why it is?
TrailBlazer666 - October 6, 2017

$FOLD upgraded $CTRV $AVXL $TBPH & $ASTI

$FOLD upgraded $CTRV $AVXL $TBPH $ONCE & $ASTI I like my US biotechs today all have good news out. Putting them on watch as the...
osirus1 - October 5, 2015

RE:RE:FOLD had two signals consecutive days!

Fold can be a big winner if it get FDA ok in near future. I can see big farma to buyout,,,,, I can be wrong but you never know what...
mark26 - September 6, 2014
View more Bullboard ››

Masivo Silver Corp.

Masivo Silver Corp.

Masivo Silver Corp. is a Canadian junior silver and gold mining exploration company based in Vancouver, Canada. The Company ...
View More »